Cite
HARVARD Citation
Liu, R. et al. (2022). Development and external validation of a nomogram for individualized adjuvant imatinib duration for high‐risk gastrointestinal stromal tumors: A multicenter retrospective cohort study. Cancer medicine. pp. 3093-3105. [Online].